|
2025
|
Invention
|
Organic acid addition salts of s-pindolol.
The invention relates to a pharmaceutically acceptabl... |
|
|
Invention
|
Salt of a pharmaceutical compound.
The invention relates to a pharmaceutically acceptable acid a... |
|
2024
|
Invention
|
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclero... |
|
|
Invention
|
Salt of s-oxprenolol. The invention relates to a pharmaceutically acceptable acid addition salt o... |
|
2022
|
Invention
|
Oral formulation.
The invention relates to a solid pharmaceutical formulation suitable for oral ... |
|
|
Invention
|
Oral formulation. The invention relates to a solid pharmaceutical formulation suitable for oral a... |
|
2021
|
Invention
|
S-enantiomerically enriched compositions of beta blockers for treating muscle weakness.
The use ... |
|
|
Invention
|
Organic acid addition salts of s-pindolol. z, where x is from 1 to 10, y is from 2 to 20 and z is... |
|
|
Invention
|
Organic acid addition salts of s-pindolol. The invention relates to a pharmaceutically acceptable... |
|
2020
|
Invention
|
Oxprenolol compositions for treating cancer. The present invention relates to compositions of S-e... |
|
|
Invention
|
S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The use o... |
|
2018
|
P/S
|
Pharmaceutical, medical and therapeutic substances and preparations; pharmaceutical, medical and ... |
|
2010
|
Invention
|
Prevention and treatment of sarcopenia. The present invention provides a means for prevention and... |
|
2007
|
Invention
|
Treatment of cachexia. The present invention provides a means for prevention and treatment of cac... |
